The primary aim of our working group is the same as the one ESC promotes; "To reduce the burden of cardiovascular disease in Europe".
Pharmacology is an extremely important aspect of most disciplines within cardiology. All cardiologists use cardiovascular drugs and we believe all cardiologist who are ESC members should join our working group to contribute and to learn.
Thus, we are an important contributor to the ESC at most levels. We work with all aspects of cardiovascular pharmacology i.e. from basic pharmacology over clinical trials to clinical pharmacology.
The activity of the working group has increased dramatically during the last years. We have now yearly scientific meetings organized by the working group focusing on cardiovascular pharmacology.
We have several other educational activities, which we plan to increase during the next years and we have recently launched a new journal within the European Heart Journal family, entitled European Heart Journal – Cardiovascular Pharmacotherapy.
Prof. Stefan Agewall (NO), FESC